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Abstract Individual differences in the rate of aging
are determined by the efﬁciency with which an
organism transforms resources into metabolic energy
thus maintaining the homeostatic condition of its
cells and tissues. This observation has been integrated
with analytical studies of the metabolic process to
derive the following principle: The metabolic stabil-
ity of regulatory networks, that is the ability of cells
to maintain stable concentrations of reactive oxygen
species (ROS) and other critical metabolites is the
prime determinant of life span. The metabolic
stability of a regulatory network is determined by
the diversity of the metabolic pathways or the degree
of connectivity of genes in the network. These
properties can be empirically evaluated in terms of
transcriptional changes in gene expression. We use
microarrays to investigate the age-dependence of
transcriptional changes of genes in the insulin
signaling, oxidative phosphorylation and glutathione
metabolism pathways in mice. Our studies delineate
age and tissue speciﬁc patterns of transcriptional
changes which are consistent with the metabolic
stability–longevity principle. This study, in addition,
rejects the free radical hypothesis which postulates
that the production rate of ROS, and not its stability,
determines life span.
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Introduction
Aging in its broadest sense is a time-related process
resulting in a progressive loss of function in an adult
individual. The process is described by an increased
probability of mortality with advancing age. This
progressive impairment of physiological function
with time has both a genetic and an environmental
component (Finch 1990). The environmental compo-
nent is indicated by the dramatic increases in mean
life span observed in human populations during the
last 150 years. The inﬂuence of genetic effects on
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ation in maximal life span. Within the mammalian
lineage, for example, maximal life span ranges from
4 years in the case of mice to 122 years in humans.
There also exist signiﬁcant variation in mortality
rates: an exponential increase in mortality with age is
typical; however, in many species, mortality rate is
known to abate with age at advanced ages (Vaupel
et al. 1998). Two main questions arise from these
empirical observations:
1. What are the evolutionary mechanisms that
underlie the large interspeciﬁc variations in
maximal life span?
2. What are the developmental processes that
underlie the observed individual variations in
maximum age of death?
These two questions have been addressed in a
mathematical model of the aging process (Demetrius
2004). This model invokes developmental and evolu-
tionary arguments to relate the stability of metabolic
networks in cells—a molecular level property—with
individual and interspeciﬁc variations in life span—
organismic and population level properties. This
article is concerned with the empirical evaluation of
the predictions of the mathematical model.
Studies of evolutionary logic of aging and its
molecular basis have a long history. We brieﬂy
delineate this history in order to better situate the
prediction of the metabolic stability theory and its
empirical support. We refer to (Dietz 2005; Olshan-
sky and Rattan 2005) for a critical account of some of
the concepts that underlie the various theories.
Evolutionary models of aging are concerned with
explaining the interspeciﬁc variation in age-speciﬁc
fecundity and mortality that characterize natural
populations. These models necessarily revolve
around the concept of Darwinian ﬁtness, that is the
efﬁciency with which organisms acquire and trans-
form resources into net-offspring production. The
explanatory power of these evolutionary models is
largely dependent on the measure of ﬁtness invoked
(Dietz 2005; Demetrius and Ziehe 2007).
Evolutionary arguments which appeal to the claim
that ﬁtness is determined by the population growth
rate (the Malthusian parameter) include the following
three models, mutation-accumulation (Medawar
1952), antagonistic pleiotropy (Williams 1957), dis-
posable soma (Kirkwood 1977). These qualitative
studies of aging have each provided insights into
various observed relations between fecundity and
mortality schedules in populations. However, as
delineated by Hamilton (1966), this class of models,
because of the Malthusian condition they implicitly
assume, entail that the intensity of selection declines
with age—a property which is inconsistent with the
existence of mortality plateaus, that is, the deceler-
ation of mortality rates at extreme ages.
The evolutionary argument based on the analyti-
cal and empirical fact that Darwinian ﬁtness is
characterized by demographic stability (a property
measured by the statistical parameter evolutionary
entropy) is a quantitative model which analytically
predicts empirically observed relations between age-
speciﬁc fecundity and mortality schedules. In the
context of this model, the intensity of selection is a
convex function of age—a condition which explains
the incidence of mortality plateaus (Demetrius 2001;
Demetrius et al. 2007). Accordingly, evolutionary
models based on entropy as Darwinian ﬁtness, have a
wider explanatory range than competing models of
aging which appeal to the Malthusian parameter as
the ﬁtness measure (Dietz 2005; Braeckman et al.
2006; Demetrius and Ziehe 2007).
Developmental models of aging are concerned
with the molecular and biochemical mechanisms that
regulate cell functions. The thrust of these models is
the characterization of the efﬁciency with which cells
acquire and transform resources into metabolic
function. Their explanatory power derives in part
from the measures of metabolic efﬁciency adduced.
The free radical theory of aging postulated by
Harman (1956) cited the deleterious effect of ROS
on cellular components to propose that the production
rate of ROS regulates metabolic efﬁciency, and hence
determines the rate of aging.
The metabolic stability theory of aging proposed
in Demetrius (2004) derives partly from the obser-
vation that ROS has two kinds of effects on metabolic
activity. First, these small diffusible molecules can
interact with DNA and RNA to impair cell function.
Second, the molecules can also act as second
messengers in signal transduction processes (Finkel
and Holbrook 2000). The dual effect of ROS suggests
that the ability of the cell to maintain stable
concentrations of ROS may play a critical role in
maintaining the functional integrity of the cell and
consequently, the rate of aging of the organism.
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these ideas and appeals to studies of the evolutionary
logic of aging (Demetrius 2001) to relate stability
properties of the metabolic networks with individual
and interspeciﬁc variations in life span.
The central concept in this study of the evolution-
ary and developmental aspects of aging is metabolic
stability—the cellular analogue of the population
parameter, demographic stability. Metabolic stability
describes the capacity of a cell to maintain steady
state concentrations of ROS and other critical
metabolites in the face of random perturbations in
the rate and activity of the enzymes in the metabolic
networks.
In Demetrius (2004), analytical models of the
dynamics of the regulatory process of the cellular
level were integrated with the dynamics of the
evolutionary process at the population level to derive:
The metabolic stability–longevity principle: The
metabolic stability of the cells in the regulatory
network is positively correlated with life span and is
the prime determinant of the rate of aging.
This article will exploit comparative studies of
age-related transcriptional proﬁles in different organs
in mice to evaluate the empirical support for this
prediction. Our empirical evaluation of the metabolic
stability–longevity principle will be based on distin-
guishing between two classes of regulatory systems.
1. Dissipative networks: These metabolic pathways
consist of enzymes that transduce physiologic
stimuli into special metabolic programs. A
canonical example of this class are the mito-
chondrial enzymes. This network provides most
of the ATP for cellular reactions and is respon-
sible for the majority of ROS production in cells.
2. Stabilizing networks: These pathways act pri-
marily as homeostatic controls of the production
of ROS and other metabolites involved in the
various metabolic programs which occur in the
mitochondria. Typical example of this class of
network are the DNA repair enzymes, stress
response pathways and, inﬂammatory response
proteins.
A large body of empirical evidence indicates that
variations in ROS concentration does lead to tran-
scriptional changes in gene expression (Johnson et al.
1999). Consequently changes in the activity of the
dissipative and stabilizing pathways will be positively
correlated with transcriptional changes in gene
expression. Now, the metabolic stability of dissipa-
tive and stabilizing networks will be both species-
speciﬁc and tissue-speciﬁc.
Species-speciﬁcity derives from the metabolic
stability principle, namely, stability is positively
correlated with maximal life span, a property of the
species. Tissue-speciﬁcity follows from the fact that
the stability of the regulatory network will be
contingent on the physiological or homeostatic con-
dition of the tissue—whether it has a high degree of
metabolic stability, with few age-regulated genes, as
in the case of the brain, or a low degree of metabolic
stability with a large number of age-regulated genes,
for example, the heart. See for example Zahn et al.
(2007).
These observations, when integrated with the
metabolic stability–longevity principle entails the
following dynamical properties of gene expression in
dissipative and stabilizing networks. (1) Transcrip-
tional changes in gene expression will vary with age.
(2) The nature and magnitude of the changes will be
both (a) tissue-speciﬁc—the percentage of regulated
genes will be small in tissues such as the brain, an
organ with a strong level of homeostasis, and (b)
species-speciﬁc—the percentage of regulated genes
willberelativelysmallintissuesoflong-lived species,
such as humans. (3) Transcriptional changes in gene
expression will be down-regulated in dissipative
networks and up-regulated in stabilizing networks.
The concept metabolic entropy, a measure of the
diversity of the metabolic pathways of energy and
information ﬂow in cells, is positively correlated with
metabolic stability (Demetrius and Manke 2005).
Now the relative contribution of a gene to metabolic
entropy increases with the connectivity of the gene,
that is the number of interaction it has with other
genes in the network (Manke et al. 2006). These
observations can be allied with the metabolic stabil-
ity–longevity principle to predict what we call:
The connectivity–lifespan principle: The sensitiv-
ity of life span to mutations in a gene in the network
increases with the connectivity of the gene.
This article applies microarray-based analysis of
gene expression and regulation in mice to assess the
empirical validity for these predictions.
Experimentalists, motivated by an interest in
understanding the dynamics of gene expression and
its age-dependent effects have carried out studies
Biogerontology (2009) 10:549–564 551
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others, with the studies described in this paper. Earlier
works (Lee et al. 1999; Cao et al. 2001; Jiang et al.
2001; Amador-Noguez et al. 2004; Fu et al. 2006;
Edwards et al. 2007; Misra et al. 2007; Zahn et al.
2007) based on microarray studies using different
platforms have demonstrated changes in gene expres-
sion with age. In all of these studies, various tissues
derived from mice of varying ages and strains were
analyzed. A consequence of this is the noticeable
differential expression in age-regulated target genes.
The study (Zahn et al. 2007) provides the most
extensive data to date. It encompasses 16 different
tissues and 4 distinct ages of the same mouse strain.
Their data suggest that there are indeed major
differences in aging mechanisms between different
tissues. Additionally, they also provide evidence that
the nature and magnitude of transcriptional changes
is age and tissue speciﬁc. An important ﬁnding is the
signiﬁcant differences in age-regulation in mice and
humans, an observation consistent with the prediction
made by Demetrius in (2004) that humans and mice
differ in terms of their life-history and metabolic
stability, hence they will age at different rates.
The studies described in this paper were inspired
by our explicit interest in assessing the empirical
validity of a mathematical model of the molecular
mechanisms underlying the aging process. Conse-
quently, our methodology and some of our ﬁndings
go beyond certain results described by Zahn et al. A
cornerstone of our study is the analysis of transcrip-
tional changes in the glutathione metabolism, insulin
signaling and oxidative phosphorylation networks. In
the context of our model, glutathione metabolism and
insulin signaling are stabilizing networks, whereas
oxidative phosphorylation is a dissipative network.
Our analysis of gene expression in these networks
will be the basis for our evaluation of the metabolic
stability theory of aging.
Materials and methods
Mice
Healthy wild type female C57BL6 mice were housed
in a room with controlled photoperiod and temper-
ature. Animals were given free access to water and
pelleted diet. Duplicate brain, heart and kidney were
collected from young (10–12 weeks) and aged
(*14 months) mice. Mice were sacriﬁced by cervi-
cal dislocation; tissues were collected, ﬂash frozen in
liquid nitrogen and stored at -80C.
RNA isolation
Total RNA was isolated from brain, heart and
kidney using the NucleoSpin
 RNA/Protein Kit
(Macherey–Nagel, Du ¨ren, Germany) and following
the manufacturers protocol. Tissue homogenization
was performed using the TissueLyser and 5 mm
Stainless Steel Beads (Qiagen, Hilden, Germany) and
homogenizing 2 times for 30 /s and with a frequency
of 30/s. The quantity and quality of the RNA was
determined using the NanoDrop (NanoDrop Tech-
nologies, Wilmington, DE, USA).
Illumina bead chip hybridisations and analysis
of mouse expression data
Biotin-labelled cRNA was produced using a linear
ampliﬁcation kit (Ambion, Austin, TX, US) with
400 ng of quality-checked total RNA as input. Chip
hybridisations, washing, Cy3-streptavidin staining,
and scanning were performed on the Illumina Bead-
Station 500 (Illumina, San Diego, CA, US) platform
using reagents and following protocols supplied by
the manufacturer. cRNA samples were hybridised
onto Illumina mouse-6 BeadChips. We hybridised the
following samples as biological duplicates: young
brain, aged brain, young heart, aged heart, young
kidney and aged kidney. All basic expression data
analysis was carried out using the manufacturer’s
software BeadStudio 1.0. Raw data were background-
subtracted and normalized using the ‘‘rank invariant’’
algorithm. Normalized data were then ﬁltered for
signiﬁcant expression on the basis of negative control
beads. Selection for differentially expressed genes
was performed on the basis of arbitrary thresholds for
fold changes plus statistical signiﬁcance according to
the Illumina t-test error model (Kuhn et al. 2004).
Differentially expressed genes were further ﬁltered
according to Gene Ontology terms or mapped to
Kegg pathways using DAVID 2006 (http://david.
abcc.ncifcrf.gov) and FatiGO? (http://babelomics.
bioinfo.cipf.es/fatigoplus/cgi-bin/fatigoplus.cgi). For
analysis, we used GenBank accession numbers rep-
resented by the corresponding chip oligonucleotides
552 Biogerontology (2009) 10:549–564
123as input. In addition, we compared our target gene
lists to published data (Zahn et al. 2007).
Real-Time polymerase chain reaction
For reverse transcription, 1.0 ll( 1lg/ll)of RNA was
addedto1.0 ll(50 lM)Oligo-dTprimerplus8.0 llof
RNase-free water (dH2O). The mixture was spun
brieﬂy andheated to70Cfor5 minandcooledonice.
10.0 ll of master mix were added including the
following components per reaction: 4.0 llo f5 9 RT
buffer,2.0 llof0.1 MDTT,2.0 llof(10 mM)dNTP,
1.0 ll(200 U/ll)SuperscriptII(Invitrogen)and1.0 ll
of dH2O. After pulse spinning, incubation was carried
out at 42C for 1.5 h. Real-Time polymerase chain
reaction (Real-Time PCR) was performed in 96-Well
Optical Reaction Plates (Applied Biosystems, Foster
City, CA, US). The PCR mix in each well included
10 ll of SYBR
Green PCR Master Mix (Applied
Biosystems),5 lldH 2O,1.5 lleachoftheforwardand
reverse primers (5 ng/ll) and 2 ll of single strand
cDNA (2.5 ng/ll) in a ﬁnal reaction volume of 20 ll.
Triplicate ampliﬁcations were carried out per gene
with three wells serving as negative controls without
template. GAPDH and ACTB were ampliﬁed along
with the target genes as endogenous controls for
normalization.ThePCRreactionwascarriedoutonthe
ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems) using the following program,
stage1,50Cfor2 min,stage2,95Cfor10 min,stage
3, 95Cfor 15 s and 60Cfor 1 min, for 40 cycles and,
stage4,95Cfor15 s,60Cfor15 sand95Cfor15 s.
The last heating step in stage 4 was performed with a
ramp rate of 2% in order to enable the generation of a
dissociation curve of the product. The output data
generated by the Sequence Detection System 2 soft-
ware were transferred to Microsoft Excel for analysis.
The differential mRNA expression of each gene was
calculated with the comparative Ct method recom-
mended by the manufacturer.
Western blotting
Protein extracts were isolated from brain, heart and
kidney using Lysis buffer (150 mM NaCl, 10 mM
Tris–HCl, 1 mM EDTA, 1% Triton-X100; pH 7.8)
and the TissueLyser (Qiagen). Protein concentrations
were measured using the Bradford method. Western
blotting was performed according to standard
procedures and using chemiluminescence detection
(ECL, Amersham). Antibodies used were Abcam
ab22604 (Gpx1), Ambion #4300 (Gapdh), Calbio-
chem #DC03L (HRP-linked), as well as Amersham
NA9310 (HRP-linked).
Results
Global data analysis
We provide experimental evidence at the molecular
level based on a genomics approach to support the
metabolic stability hypothesis. To identify and further
analyse common and tissue-speciﬁc metabolic path-
ways and metabolism-related biological processes
altered with age in mice, RNA was isolated from the
brain, heart and kidney of young (10–12 weeks) and
aged (*14 months) C57/Bl6 female mice. Whole-
genome gene expression analyses employing the
Illumina Bead Chip technology was then used to
proﬁle the transcriptomes of these tissues. We used
the rank invariant method for normalisation and the
t-test error model.
Data reproducibility is demonstrated by sample
correlation and clustering (Fig. 1a, b). As expected
the clustering of the samples shows a good correla-
tion within the same tissue type. Furthermore, the
correlation coefﬁcient of samples of the same tissue
is high ([0.9). However, the transcriptional differ-
ence between young and aged samples of the same
tissue is minor—the correlation coefﬁcients for
biological replicates range from 0.97 to 0.99 and
for young versus aged samples from 0.94 to 0.99. Of
the three tissue types analysed, the heart samples
show the best separation between young and aged
tissues. The differences between samples of the same
tissue type could also reﬂect heterogeneity between
biological replicates indicating minor differences in
mRNA levels between our two age groups. This is
also reﬂected by the results of our differential gene
expression analysis between young and aged tissues.
Normalized data were analysed for signiﬁcant
(detection[0.99 for at least one group and P
value\0.05) changes in gene expression between
young and aged samples with ratios of 1.3 and above
(Full data provided as Table S1 in Electronic
supplementary material). To identify a signiﬁcant
number of age-related regulated genes for further
Biogerontology (2009) 10:549–564 553
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gene expression levels (fold change[10) are hardly
or even never observed with aging (Lee et al. 1999;
Cao et al. 2001; Jiang et al. 2001; Amador-Noguez
et al. 2004; Fu et al. 2006; Edwards et al. 2007; Misra
et al. 2007). For the chosen criteria, we found more
regulated genes in heart (740) and kidney (695) than
in brain (448) including duplicate counts for genes
represented more than once on the chip. The total
number of age-related genes is shown in Fig. 1c.
The age-related gene lists (corresponding Gene
accession as input) were further analysed using the
Gene Annotation Tools—DAVID (http://niaid.abcc.
ncifcrf.gov/) and FatiGO? (http://babelomics.bioinfo.
cipf.es/fatigoplus/cgi-bin/fatigoplus.cgi) to identify
altered pathways and Gene Ontologies. Table 1 lists
signiﬁcant metabolic processes (GO: biological
process) in brain, heart and kidney for which the
respective genes within these processes are
differentially regulated in young and aged mice.
Several metabolic processes are regulated in an age-
dependent manner. As expected from the number of
regulated genes, we found fewer and more global
processes for brain (e.g., protein and cellular metab-
olism) than in heart (e.g., phosphate and cofactor
metabolism) and kidney (e.g., hexose and cellular
lipid metabolism). Table 1 shows all processes that
include the word metabolism. It is therefore a sub-
group of the original DAVID output where we found
24 regulated processes for brain (4 metabolic pro-
cesses), 88 for heart (21 metabolic processes) and 79
for kidney (22 metabolic processes). Beside the
metabolic-related processes we found for instance
apoptosis and transport-related processes. Table 2
lists results for Kegg and Biocarta annotated path-
ways in heart. In brain, only one Kegg annotated
pathway (neurodegenerative disorders) was found
and in kidney glutathione metabolism, natural killer
cell mediated cytotoxicity, and antigen processing
and presentation showed signiﬁcant regulation (data
not shown). For the purpose of this study, we would
like to focus on the heart where we see indications of
differential expression of relevant gene components
of glutathione metabolism, insulin signaling and
oxidative phosphorylation.
Glutathione metabolism
Glutathione (GSH) plays a critical role in many
biological processes (Maher 2005). The main func-
tion/requirement of GSH and its metabolism is to
regulate homeostasis by decreasing reactive oxygen
species (ROS), which are produced either endoge-
nously e.g., during respiration in the mitochondria
(Murakami 2006) or exogenously e.g., by UV
radiation. Three major components constitute gluta-
thione metabolism; biosynthesis of glutathione in its
reduced monomeric form (GSH), antioxidant func-
tion by forming glutathione disulfate (GSSG;
oxidized glutathione), and the detoxiﬁcation by
conjugating toxic rests (e.g., peroxidised lipids and
xenobiotics) to glutathione.
Our data on aged heart, revealed up-regulated
expression of key enzymes encoded by the following
genes, Gclm, Gpx1, Gpx3, Gsta2 and Gstm2 (Table 3,
Fig. 2a), which were also conﬁrmed by Real-Time-
PCR (Fig. 3a). In addition, protein expression of
Gpx1 was evaluated by western blotting in all three
Fig. 1 Results of the global expression data analysis. a
Clustering of all samples analysed and b the corresponding
linear correlation factors. c Numbers of signiﬁcant (detec-
tion[0.99 for at least one group and P value\0.05) changes
in gene expression between young and aged tissues with ratios
of 1.3 and above
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Term Count
a (%)
b P value
c
Brain
Biopolymer metabolism 54 13.95 2.0E-02
Metabolism 136 35.14 2.0E-02
Protein metabolism 61 15.76 3.4E-02
Cellular metabolism 126 32.56 3.6E-02
Heart
Metabolism 274 43.70 2.9E-12
Cellular metabolism 259 41.31 7.4E-12
Primary metabolism 246 39.23 1.2E-10
Macromolecule metabolism 164 26.16 5.5E-09
Protein metabolism 129 20.57 4.8E-08
Cellular macromolecule metabolism 124 19.78 6.8E-08
Cellular protein metabolism 122 19.46 1.1E-07
Biopolymer metabolism 103 16.43 2.1E-05
Phosphorus metabolism 37 5.90 5.0E-03
Phosphate metabolism 37 5.90 5.0E-03
Cofactor metabolism 14 2.23 5.9E-03
Heterocycle metabolism 7 1.12 6.4E-03
Regulation of protein metabolism 14 2.23 7.9E-03
Sphingoid metabolism 4 0.64 2.5E-02
Nitrogen compound metabolism 17 2.71 2.6E-02
Amine metabolism 16 2.55 3.2E-02
Coenzyme metabolism 11 1.75 3.5E-02
Nucleobase, nucleoside, nucleotide and nucleic acid metabolism 102 16.27 3.8E-02
Amino acid and derivative metabolism 14 2.23 4.2E-02
Negative regulation of metabolism 14 2.23 4.7E-02
Kidney
Metabolism 254 41.85 3.1E-07
Cellular metabolism 237 39.04 1.6E-06
Primary metabolism 224 36.90 1.1E-05
Carboxylic acid metabolism 23 3.79 6.3E-03
Organic acid metabolism 23 3.79 6.3E-03
Macromolecule metabolism 133 21.91 6.7E-03
Protein metabolism 103 16.97 8.5E-03
Hexose metabolism 10 1.65 9.4E-03
Monosaccharide metabolism 10 1.65 1.0E-02
One-carbon compound metabolism 5 0.82 1.1E-02
Alcohol metabolism 14 2.31 1.3E-02
Cellular macromolecule metabolism 97 15.98 1.6E-02
Glucose metabolism 8 1.32 1.9E-02
cellular protein metabolism 95 15.65 2.0E-02
Cellular lipid metabolism 21 3.46 2.4E-02
Nitrogen compound metabolism 17 2.80 2.5E-02
Steroid metabolism 9 1.48 3.1E-02
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with age, whereas the expression in brain and kidney
was unaffected, which was also observed for gene
expression (Fig. 3b). An overlapping regulation of
the transcriptome and proteome will not necessarily
be observed for all genes, however the overall trend
of regulation in different biological processes on the
gene level may also be observed at the protein level.
The synthesis of glutathione involves a 2-step
ligation reaction. First glutamate–cysteine ligase
(Gcl) conjugates L-glutamate and cysteine to
L-gamma-glutamylcysteine, which is then further
ligated to glycine by glutathione synthetase (Gs).
The modiﬁer subunit of Gcl named Gclm is 1.6-
fold up-regulated in aged heart. There are several
isozymes of glutathione peroxidases (Gpx) encoded
by the different genes which reduce lipid hydro-
peroxides to their corresponding alcohols and free
hydrogen peroxide to H2O. These enzymes have
varied cellular location and substrate speciﬁcity. For
example, glutathione peroxidase 1 (Gpx1; 2.2-fold
up-regulated in aged heart) is the most abundant
and found in the cytoplasm of nearly all mamma-
lian tissues, its preferred substrate is hydrogen
peroxide H2O2. The expression pattern of glutathi-
one peroxidase 3 (Gpx3), which is 1.4-fold up-
regulated in aged heart, is not as ubiquitously
expressed as Gpx1 (Maher 2005). Finally, the
detoxiﬁcation component of glutathione metabolism
is established by different glutathione S-transferases
(GST). The GST family of enzymes comprises a
long list of cytosolic, mitochondrial, and micro-
somal proteins which are capable of multiple
reactions with a multitude of substrates, both
endogenous and xenobiotic. Members of the alpha
(Gsta2) and mu (Gstm2) class are 1.7-fold and
Table 1 continued
Term Count
a (%)
b P value
c
Amine metabolism 16 2.64 3.1E-02
Regulation of metabolism 79 13.01 4.0E-02
Amino acid metabolism 12 1.98 4.5E-02
Glutamine family amino acid metabolism 4 0.66 4.5E-02
a Number of genes from the target input genes annotated for the corresponding term
b Percentage of annotated target genes compared to the overall number of input
c P values\0.05 were counted as signiﬁcant
Table 2 Age-related differential expression of genes in mouse
heart
Term Count
a (%)
b P value
c
Regulated with age
Kegg
Ribosome 10 1.59 2.7E-02
Oxidative phosphorylation 11 1.75 3.7E-02
Glutathione metabolism 6 0.96 4.7E-02
Biocarta
IL 6 signaling pathway 5 0.80 7.3E-03
IL 2 signaling pathway 4 0.64 4.0E-02
IGF-1 Signaling Pathway 4 0.64 4.0E-02
Insulin Signaling Pathway 4 0.64 4.7E-02
Up with age
Kegg
Glutathione metabolism 5 1.89 1.3E-02
Biocarta
IL 2 signaling pathway 3 1.13 6.7E-02
IGF-1 Signaling Pathway 3 1.13 6.7E-02
IL 6 signaling pathway 3 1.13 7.1E-02
Insulin Signaling Pathway 3 1.13 7.5E-02
Down with age
Kegg
Ribosome 10 2.74 3.6E-04
Oxidative phosphorylation 11 3.01 3.8E-04
Citrate cycle (TCA cycle) 4 1.10 3.2E-02
Proteasome 4 1.10 3.5E-02
Purine metabolism 8 2.19 5.4E-02
Pyrimidine metabolism 6 1.64 5.8E-02
a Number of genes from the target input genes annotated for
the corresponding term
b Percentage of annotated target genes compared to the overall
number of input
c P values\0.05 were counted as signiﬁcant, but the whole
output is shown
556 Biogerontology (2009) 10:549–564
1231.6-fold up-regulated in aged heart, respectively
(Table 3).
In aged brain and kidney we could not ﬁnd this
signiﬁcant up-regulation of Gclm, Gpx1, Gpx3, Gsta2
and Gstm2. In brain, Gclm shows constant expression
levels between young and aged samples, Gpx1 and
Gpx3 seem to be slightly up-regulated with age and
Gsta2 and Gstm2 are not detected. In kidney, all ﬁve
genes are expressed but just Gsta2 is signiﬁcantly
down-regulated with age (data not shown).
Insulin signaling
Insulin is a key molecule implicated in the aging
process and it is known to be involved in life
extension in many mutant mouse models (Kenyon
2005). Its main function is the regulation of glucose
homeostasis, but it also indirectly regulates lipid
homeostasis (Fig. 2b).
We found regulation of key enzymes of the insulin
signaling pathway in aged heart (Foxo1, Pdpk1 and
Pfkl). 3-Phosphoinositide dependent protein kinase-1
(Pdpk1; 1.4-fold up-regulated in aged heart) has a
central role in mediating a variety of cascades within
the insulin signaling pathway by phosphorylating
many diverse kinases (King and Newton 2004).
Downstream of Pdpk1, forkhead box O1 (Foxo1;
2.1-fold up-regulated in aged heart), a member of the
FOXO family of forkhead transcription factors, acts as
a key regulator that induces the expression of genes
Table 3 Age-dependent gene expression in the context of glutathione metabolism, insulin signaling and oxidative phosphorylation
in mouse heart
Symbol Accession Deﬁnition P value
a Ratio
b
Glutathione metabolism
Gclm NM_008129 Glutamate–cysteine ligase, modiﬁer subunit 2.5E-02 1.56
Gpx1 NM_008160 Glutathione peroxidase 1 2.2E-02 2.21
Gpx3 NM_008161 Glutathione peroxidase 3 1.4E-02 1.41
Gsta2 NM_008182 Glutathione S-transferase, alpha 2 (Yc2) 4.4E-02 1.74
Gstm2 NM_008183 Glutathione S-transferase, mu 2 4.2E-03 1.56
Insulin signaling
Foxo1 NM_019739 Forkhead box O1 3.5E-02 2.10
Map2k1 NM_008927 Mitogen activated protein kinase kinase 1 9.2E-03 0.57
Pdpk1 NM_011062 3-Phosphoinositide dependent protein kinase-1 4.6E-02 1.38
Pfkl NM_008826 Phosphofructokinase, liver, B-type 2.9E-03 1.38
Rapgef1 NM_054050 Rap guanine nucleotide exchange factor (GEF) 1 2.7E-02 1.39
Oxidative phosphorylation
Atp5a1 NM_007505 ATP synthase, H? transporting, mitochondrial F1 complex, alpha subunit, isoform 1 4.5E-02 0.72
Atp5f1 AK002960 ATP synthase, H? transporting, mitochondrial F0 complex, subunit b, isoform 1 4.6E-02 0.76
Cox7a2 NM_009945 Cytochrome c oxidase, subunit VIIa 2 4.5E-02 0.71
Cox7b NM_025379 Cytochrome c oxidase subunit VIIb 2.0E-02 0.51
Ndufa5 NM_026614 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 7.4E-03 0.70
Ndufb2 NM_026612 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 4.0E-02 0.51
Ndufb4 NM_026610 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 3.7E-03 0.46
Np15 NM_019435 Nuclear protein 15.6 1.3E-02 0.77
Uqcrb NM_026219 Ubiquinol–cytochrome c reductase binding protein 9.1E-03 0.76
a P values\0.05 were counted as signiﬁcant
b Ratios were calculated for aged over young
Fig. 2 Age-dependent changes in glutathione metabolism (a)
insulin signaling (b) and oxidative phosphorylation (c). The
FatiGO? output shows regulated genes in glutathione metab-
olism, insulin signaling and oxidative phosphorylation using
Kegg pathways. Two different target gene lists were processed
simultaneously and are shown in different colours. Green and
red boxes indicate increased and decreased expression levels
respectively (Coloured version is provided in the online
version). The corresponding genes are shown in Table 3
c
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123involved in gluconeogenesis and glycolysis in
responsetoinsulin(Aoyamaetal.2006).Additionally,
thephosphofructokinasePfkl(1.4-foldup-regulatedin
aged heart) catalyses a key step in glycolysis, namely
the conversion of D-fructose 6-phosphate to D-fructose
1,6-bisphosphate. Furthermore, mitogen activated
protein kinase kinase 1 (Map2k1) and Rap guanine
nucleotide exchange factor (GEF) 1 (Rapgef1) are
0.6-fold down- and 1.4-fold up-regulated in aged
heart, respectively (Table 3).
Oxidative phosphorylation
Oxidativephosphorylationisametabolicpathwaythat
uses energy released by the oxidation of nutrients to
produce adenosine triphosphate (ATP). We found
down-regulation of enzymes in four of the ﬁve
complexes in the electron transport chain in aged
heart.AspartofcomplexI,theNADHdehydrogenases
Ndufa5, Ndufb2, Ndufb4 and Np15 were down-regu-
lated 0.70-, 0.51-, 0.46- and 0.77-fold, respectively.
Ubiquinol–cytochrome c reductase binding protein
(Uqcrb;complexIII)is0.76-foldandthecytochromec
oxidases Cox7a2 and Cox7b (complex IV) are 0.71-
and 0.51-fold down-regulated. Finally, the ATP syn-
thases Atp5a1 and Atp5f1 of complex V are 0.72- and
0.76-fold down-regulated (Table 3, Fig. 2c).
Novel and conserved age-related target genes
To identify conserved age-related genes we compared
our data to the target genes identiﬁed by the most
comprehensive study on age-related gene expression
(Zahn et al. 2007). The result of this comparison is
presented in Table S2. In addition, we provide a list
of putative novel age-related target genes expressed
in brain, heart and kidney (Table S3).
Discussion
The metabolic stability–longevity principle asserts
that metabolic stability, that is the ability of cells to
maintain stable concentrations of ROS and other key
metabolites in the regulatory network, is the prime
determinant of life span.
This principle was given analytical support by
formulating a mathematical model of the aging
process based on a formal representation of the
metabolic stability concept (Demetrius 2004). The
theory focuses on two classes of regulatory pathways:
networks which transduce physiological stimuli by
stimulating mitochondrial activity—dissipative sys-
tems; and networks which are involved in the
regulation of ROS and other metabolites generated
by the mitochondrial enzymes—stabilizing networks.
By appealing to the metabolic stability–longevity
principle, and invoking a correlation between meta-
bolic entropy—a measure of diversity of energy ﬂow
in the network, and metabolic stability—the resil-
ience of ROS concentrations to random perturbation
in enzymatic reaction rates, we predicted a series of
correlations between the following pairs of proper-
ties. (1) Transcriptional changes in gene expression
and the tissue type and the taxon status of the
organism. (2) The direction of regulation (up and
Fig. 3 Independent conﬁrmation of the array-derived data. a
Real-Time PCR conﬁrming the expression ratios for genes
involved in glutathione metabolism in the heart. b Western blot
based conﬁrmation of Gpx1 protein expression in brain, heart
and kidney. The upper part shows the protein expression for all
three tissues with equally loaded amounts of protein (15 lg). In
the second case, 30 lg protein was loaded for brain and heart
and 15 lg for kidney. The expression of Gapdh was used to
monitor equal loading of protein
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123down) and the metabolic function (dissipative or
stabilizing) of the regulatory networks. (3) The
patterns of interactions or connectivity of the network
and the sensitivity of life span to mutations that affect
the activity of genes in the network.
The empirical design described in this article is
aimed at assessing the validity of these predictions by
a study of gene proﬁling in the glutathione metabo-
lism, insulin signaling (stabilizing networks) and
oxidative phosphorylation pathways (dissipative
network).
The data set in our empirical design is qualitative
and comprehensive. The quality of the data set was
rigorously tested in several ways including numerous
statistical tests. A comparison of the expression
proﬁles derived from biological duplicates revealed
some variation which may be accounted for by, (1)
technical variability attributed to the loss of tran-
scripts during cRNA generation and hybridisations,
(2) biological variability which reﬂects the expected
heterogeneity amongst mice of even the same strain.
Gene expression in brain, heart and kidney
One of the main predictions of the theory is that
transcriptional changes in gene expression will be
contingent on the demographic stability of the species
and the intrinsic metabolic stability of the tissue.
Accordingly, patterns of gene expression will be
species-speciﬁc: they will differ between mice
(opportunistic species; characterized by weak demo-
graphic stability), and humans (equilibrium species
deﬁned by strong demographic stability). In addition,
the percentage of regulated genes in the network will
decrease with the metabolic stability of the tissue or
organ type.
The comparative studies of transcriptional changes
in mice and humans reported in Zahn et al. (2007) are
consistent with the prediction that patterns of gene
expression are species-speciﬁc. The study reported in
this paper has focused uniquely on mice. We
compared gene expression in the brain, heart and
kidney in young and aged mice. Our data indicates
that aging of mouse brain, heart and kidney is
accompanied by changes in their metabolic state.
Global gene expression analysis revealed regulation
of a variety of metabolic processes at the transcrip-
tional level in all three tissues. However, the target
gene lists of age-regulated genes for the different
tissues do not strongly overlap on the gene level
which conﬁrms the proposed variation of organ type
and age predicted by the metabolic stability theory.
Additionally, the percentage of regulated genes in the
group of all expressed genes in the three tissues
varies with 3.26% in brain, 7.74% in heart and 6.10%
in kidney. Brain, as expected to be a metabolically
stable organ seems to be less regulated with age than
heart and kidney. This observation is consistent with
the prediction of the theory. Other studies (Fu et al.
2006; Zahn et al. 2007) investigating different tissues
in parallel also found differences in gene regulation
between distinct tissues. In particular, the study by
Zahn et al. (2007) supports our empirical work.
Although their results show controversial numbers of
regulated genes, this could be due to different
threshold settings and the divergent goals of these
studies.
These empirical observations should be contrasted
with certain implications of the free radical theory of
aging proposed by Harman (1956). This theory
essentially ignores the fact that ROS is implicated as
speciﬁc signaling molecules and is critical in main-
taining normal cell functions. According to the free
radical theory, ROS are toxic byproducts of metabo-
lism in an aerobic milieu. Hence the production rate of
ROS will be negatively correlated with life span and
hence constitute the prime determinant of aging. This
proposition entails that changes in gene expression
will be largely independent of the function of the
regulatory networks and the homeostatic condition of
the various tissues. The comparative studies we have
discussed in this article point to speciﬁcity of
transcriptional changes in gene expression at the
network, tissue and species level. This observation is
inconsistent with the free radical theory.
Metabolic pathways and nature of regulation
An important prediction of the theory is the relation
between the direction of regulation and the function
of the network: Transcriptional changes in gene
expression will be down-regulated in dissipative
networks and up-regulated in stabilizing networks.
Our empirical evaluation of this prediction was
based on heart where we found signiﬁcant regulation
of glutathione metabolism, insulin signaling and
oxidative phosphorylation. The brain and kidney, in
contrast to the heart, have a relatively high degree of
560 Biogerontology (2009) 10:549–564
123metabolic stability and contain few age-regulated
genes (Zahn et al. 2007). Accordingly, these tissues
were not considered in our analysis.
Glutathione acts as an antioxidant and is thus
involved in ROS regulation, whereas the insulin
signaling pathway is involved in glucose homeosta-
sis. These two pathways are stabilizing networks.
Oxidative phosphorylation is a metabolic energy
pathway involved in ROS production and thus
constitutes a dissipative network. The metabolic
stability theory predicts that transcriptional changes
in gene expression will be up-regulated in the
glutathione and insulin signaling pathways, and
down-regulated in the oxidative phosphorylation
network.
Our empirical studies are consistent with these
predictions. Table 4 describes the three regulatory
networks, their metabolic and regulatory activity and
the direction of gene regulation. The subsequent
sections ‘‘Glutathione metabolism and ROS regula-
tion’’, ‘‘Insulin signaling and regulation’’ and
‘‘Oxidative phosphorylation’’ discuss in detail the
activity of various genes in the networks and the
mechanism whereby the regulatory activity is
achieved. A recent study (Yanker et al. 2008) docu-
ments transcriptional changes in age-related pathways
in the brain in mice and humans. The directional
changes in the dissipative and stabilizing networks are
consistent with the predictions we have stated.
Glutathione metabolism and ROS regulation
In the heart, 5 relevant genes (Gclm, Gpx1, Gpx3,
Gsta2 and Gstm2) of the glutathione metabolism
network exhibit up-regulated expression with age.
These genes are involved in all three components of
the pathway—biosynthesis of glutathione in its
reduced monomeric form (GSH), antioxidant func-
tion by forming glutathione disulfate (GSSG;
oxidized glutathione), and the detoxiﬁcation by
conjugating toxic rests (e.g., peroxidised lipids and
xenobiotics) to glutathione.
The synthesis of glutathione involves a two-step
ligation reaction. First glutamate–cysteine ligase
(Gcl) conjugates L-glutamate and cysteine to L-
gamma-glutamylcysteine, which is then further
ligated to glycine by glutathione synthetase (Gs).
Gcl is the ﬁrst rate-limiting enzyme of glutathione
synthesis (Maher 2005). The enzyme consists of two
subunits, a heavy catalytic subunit (glutamate–cys-
teine ligase catalytic subunit; Gclc) and a light
regulatory subunit (glutamate–cysteine ligase modi-
ﬁer subunit; Gclm). In most tissues, Gclm is limiting,
suggesting an increase in Gclm alone would increase
L-gamma-glutamylcysteine synthesis (Chen et al.
2005). This therefore would imply that an increase
of Gclm alone leads to increased levels of glutathione
within the cell.
The antioxidant function of glutathione metabo-
lism is accomplished by glutathione peroxidases-
Gpx. The function of these enzymes is to reduce lipid
hydroperoxides to their corresponding alcohols and to
reduce free hydrogen peroxide to H2O. Therefore,
elevated activities of Gpx might counteract increased
levels of ROS and thus maintain homeostasis.
GSTs catalyse the conjugation of reduced gluta-
thione to a wide variety of substrates. This activity is
useful in the detoxiﬁcation of endogenous com-
pounds such as oxidised lipids as well as the
metabolism of xenobiotics (Mannervik and Danielson
1988; Coles and Kadlubar 2005; Hayes et al. 2005).
Insulin signaling and regulation
Foxo1 is one of the regulated genes within the insulin
signaling pathway (Table3). In C. elegans, the
ortholog DAF-16 has been implicated in the aging
process (Curran and Ruvkun 2007). The FOXO
family of forkhead transcription factors are key
regulators that induce the expression of genes
involved in gluconeogenesis and glycolysis (Fig. 2b).
In addition, insulin signaling is known to mediate
other signaling pathways such as TOR signaling. TOR
is a serine/threonine protein kinase that regulates cell
Table 4 Overview of
pathways regulated with
age in mouse heart
Nature of network Function of network Regulatory action
Glutathione metabolism Antioxidant Up-regulation
Insulin signaling Glucose homeostasis Up-regulation
Oxidative phosphorylation ROS production rate Down-regulation
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123growth, cell proliferation, cell motility, cell survival,
protein synthesis, and transcription (Hay and Sonen-
berg 2004; Beevers et al. 2006). Current research
indicates that TOR integrates the input from multiple
upstream pathways, including insulin growth factors
(such as IGF-1 and IGF-2), and mitogens (Hay and
Sonenberg 2004). TOR is related to increased respi-
ration and extended life span by reducing TOR
signaling in Saccharomyces cerevisiae and inhibition
of this pathway leads to extended life span in several
model organisms (Bonawitz et al. 2007). In this
regard, it is therefore not surprising that mice deﬁcient
in S6K1 (an effector of TOR) are hypersensitive to
insulin and are protected against age- and diet-induced
obesity (Blagosklonny 2007).
Oxidative phosphorylation
Oxidative phosphorylation is a metabolic pathway
that uses energy released by the oxidation of nutrients
to produce ATP. It has been shown that administering
rapamycin (an antagonist of TOR) to yeast increases
expression of genes involved in the TCA cycle,
mitochondrial ribosome biogenesis and the assembly
of oxidative phosphorylation complexes (Shamji
et al. 2000). Referring to Table 2, we observed
decreases in oxidative phosphorylation, TCA cycle
and ribosome where ﬁve of ten genes linked to the
ribosome are of the large subunit of the mitochondrial
ribosome. Although these studies investigated yeast,
a review on TOR signaling implicates the involve-
ment of this pathway in heart disease in mammals
and also the involvement of TOR in the biogenesis of
ribosomes (Wang and Proud 2006).
Network connectivity and the rate of aging
Analytical studies of the relation between metabolic
entropy and metabolic stability can be integrated with
the metabolic-stability life span principle to predict:
The network connectivity–lifespan principle: The
sensitivity of life span to mutations in the gene of the
regulatory network increases with the number of
interactions or connectivity among genes in the
network.
The insulin signaling, glutathione metabolism and
oxidative phosphorylation pathways have varying
degrees of connectivity. The networks are described
in Fig. 4 and indicate that connectivity is highest in
the insulin signaling pathway. Accordingly, muta-
tions of genes in this pathway will have the largest
effect on life span.
Our evaluation of the prediction will be based on
our experimental observations and related studies.
Although we have not shown the regulation of TOR
on the RNA level or its protein phosphorylation
status, we found many indications for a TOR-
dependent regulation. This regulation includes the
observed changes in gene expression of related
pathways (insulin signaling, oxidative phosphoryla-
tion, ribosome and TCA cycle) and in addition, two
important metabolites (glucose and ROS). An
increase in insulin signaling leads to an increase in
TOR signaling which leads, as discussed above, to
Fig. 4 Proposed model of an age-related regulatory network
operative in mouse heart. Based on our results, glutathione
metabolism and insulin signaling are positively regulated
whereas oxidative phosphorylation, ribosome and TCA cycle
are negatively regulated in the aged mouse heart (Table 2).
From the literature we found indications that increased insulin
signaling leads to increased TOR signaling which then induces
a reduction in the levels of expression of oxidative phosphor-
ylation, ribosome and TCA cycle related genes (Shamji et al.
2000). The negative regulation of mitochondrial ribosomes
additionally leads to decreased respiration functionality.
Additionally, insulin signaling regulates (r.) glucose levels.
Glucose is also linked to the TCA cycle via glycolysis/pyruvate
and, the TCA cycle is then further linked to complex II
(fumarate reductase) and to complex I (NADH dehydrogenase)
of the respiration chain via fumarate/succinate and NADH,
respectively. It has been proposed by Bonawitz et al. (2007)
that decreases in oxidative phosphorylation lead to increases in
ROS which eventually leads to an increase in glutathione
metabolism
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123decreases in oxidative phosphorylation, ribosome and
TCA cycle. A decrease in oxidative phosphorylation
alters ROS levels (Bonawitz et al. 2007) which in
turn induces the regulation of glutathione metabo-
lism. This cascade indicates that changes in insulin
signaling will have more impact on the network than
for instance changes in glutathione metabolism, as
predicted by the theory.
Analyses by Promislow (2004) and Manke et al.
(2006) are computational studies which provide
additional support for the principle relating gene
connectivity and life span.
Promislow in an analysis of the yeast interaction
network compared patterns of connectivity for sub-
sets of proteins associated with aging and certain
other traits such as replicative senescence, the cell
cycle, radiation sensitivity and DNA silencing, and
salt tolerance. It was found that a protein’s connec-
tivity is positively correlated with the number of traits
it inﬂuences.
Manke et al. analysed functional data provided by
gene knockouts and RNAi experiments in yeast and
C. elegans. Proteins were classiﬁed as ‘viable’ or
‘lethal’ according to whether the organism survives
the removal of the protein or not. The computational
studies showed that proteins with the highest degrees
of connectivity tend to be lethal.
The brace of numerical investigations underscore
the validity of the connectivity–lifespan principle and
suggest that candidates for genes associated with
senescence are more likely to be located in proteins
deﬁned by a high degree of connectivity.
Conclusion
The rate of aging is determined by the efﬁciency with
which organisms acquire and transform energy into
metabolic work. The metabolic stability theory of
aging appeals to a mathematical model of aging to
show that metabolic stability, that is the capacity of a
regulatory network to maintain stable concentrations
of ROS and other critical metabolites, characterizes
this metabolic efﬁciency, and is the main determinant
of senescence. The model predicts that it is not the
rate of production of ROS that determines the rate of
aging, but the dynamic stability of concentration
levels of ROS and other metabolites that regulate
normal cell functions.
Transcriptional changes in gene expression
constitute a biomarker of metabolic stability. Com-
parative studies of transcriptional gene regulation in
glutathione metabolism, insulin signaling and oxida-
tive phosphorylation, networks commonly associated
with aging, have provided support for the metabolic
stability theory. These studies reject the free radical
theory of aging, and furthermore underscore the
systemic effects of the aging process.
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